Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong
· Delayed Price · Currency is HKD 4.720
+0.270 (6.07%)
Mar 10, 2026, 1:33 PM HKT
Lepu Biopharma Revenue
Lepu Biopharma had revenue of 465.94M CNY in the half year ending June 30, 2025, with 203.44% growth. This brings the company's revenue in the last twelve months to 700.45M, up 241.55% year-over-year. In the year 2024, Lepu Biopharma had annual revenue of 367.79M with 63.21% growth.
Revenue (ttm)
700.45M CNY
Revenue Growth
+241.55%
P/S Ratio
10.46
Revenue / Employee
1.28M CNY
Employees
546
Market Cap
8.03B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbisko Cayman | 681.17M |
| Alphamab Oncology | 861.24M |
| CK Life Sciences Int'l., (Holdings) | 5.49B |
| CStone Pharmaceuticals | 221.89M |
| Shanghai Haohai Biological Technology | 2.75B |
| HBM Holdings | 908.35M |
| CARsgen Therapeutics Holdings | 139.84M |
| Ocumension Therapeutics | 595.79M |